Role of Troponin I and D-Dimer in Detection CVD in Coronavirus Patients

Abstract Background: The virus known as serious intense respiratory disease coronavirus 2 (SARS-CoV-2) is the source of the coronavirus infection, also known as COVID-19. Subsequently, the initial COVID-19 information in December 2019. Objectives: The present study aimed to the SARS-COV-2 detection strong positive and Study the virus effect on the heart. Materials and Methods: This is a case–control study design accompanied for dated from March to October 2022. Two case-control groups with 108 people each were enrolled in this study. The case group consisted of 54 patients with SARS-COV2 and CVD, all of whom were admitted to the intensive care unit (ICU) in Marjan, Babylon. There were 54 patients in the control group in this investigation. The group of control in this study comprised 54 issues. Result: The patient and control subjects’ demographic characteristics. The study’s findings show that, of the four age categories into which the samples were split, the largest percentage of patients with COVID-19 and CVD patients (48.1% and 66.7%, respectively) are in the age group of patients who are at least 66 years old. Furthermore, there is a notable difference in the mean D-dimer levels between patients with COVID-19 (1268.07±479 ng/ml) and control subjects (267.91±62.595 ng/ml). Although the mean D-dimer for CVD patients was significantly greater than that of the control group (1824.21±1634.92 ng/ml), it was still 1648.54±1428.63 ng/ml. In contrast to patients with COVID-19 alone, patients with cardiovascular disease have higher average D-dimer concentrations. The interpretation of these results may be due to the interaction between COVID-19 and cardiovascular illnesses on the rise in D-dimer levels. When the two factors are present in the same patient group, the raised D-dimer level in patients with COVID-19 and cardiovascular disease is increased. According to the current investigation, patients with COVID-19 and CVD had significantly higher mean troponin levels than control participants (1.734±1.506 ng/mL vs. 0.035±0.024 ng/mL, respectively). Conclusion: The study came to the conclusion that older people had a higher risk of cardiovascular disease and Covid disease. a significant proportion of Covid19 and CVD patients, and CVD patients only passed away in hospitals when they were monitored for the duration of this study. The study revealed highly statistically significant associations suggesting that patients with Covid and CVD group had significantly higher levels of dimer and troponin than individuals with CVD alone. Nonetheless, when it comes to troponin levels, patients with Covid19 only differ noticeably from healthy individuals.